Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Papillomavirus Infections | 16 | 2021 | 316 | 5.510 |
Why?
|
| Papillomavirus Vaccines | 8 | 2021 | 136 | 3.710 |
Why?
|
| Health Knowledge, Attitudes, Practice | 11 | 2022 | 790 | 3.170 |
Why?
|
| Puerto Rico | 30 | 2023 | 1352 | 2.740 |
Why?
|
| HIV Infections | 15 | 2023 | 2207 | 2.180 |
Why?
|
| Anus Neoplasms | 5 | 2017 | 47 | 2.080 |
Why?
|
| Substance Abuse, Intravenous | 5 | 2023 | 123 | 2.030 |
Why?
|
| Acquired Immunodeficiency Syndrome | 3 | 2017 | 214 | 1.480 |
Why?
|
| Parents | 4 | 2021 | 288 | 1.460 |
Why?
|
| Patient Acceptance of Health Care | 5 | 2021 | 375 | 1.430 |
Why?
|
| Sexually Transmitted Diseases | 4 | 2014 | 165 | 1.260 |
Why?
|
| Sexual Behavior | 6 | 2017 | 587 | 1.250 |
Why?
|
| Adult | 31 | 2017 | 11034 | 1.240 |
Why?
|
| Heroin Dependence | 4 | 2011 | 23 | 1.230 |
Why?
|
| Young Adult | 20 | 2017 | 4012 | 1.230 |
Why?
|
| Hepatitis C | 2 | 2023 | 120 | 1.080 |
Why?
|
| Male | 33 | 2022 | 18870 | 1.050 |
Why?
|
| Middle Aged | 25 | 2017 | 9642 | 1.050 |
Why?
|
| Humans | 41 | 2023 | 34853 | 0.960 |
Why?
|
| Adolescent | 17 | 2017 | 5035 | 0.950 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2017 | 248 | 0.910 |
Why?
|
| Vegetables | 2 | 2014 | 135 | 0.900 |
Why?
|
| Drug Users | 1 | 2023 | 42 | 0.890 |
Why?
|
| Fruit | 2 | 2014 | 159 | 0.890 |
Why?
|
| Risk Factors | 11 | 2023 | 3414 | 0.780 |
Why?
|
| Female | 22 | 2022 | 19873 | 0.770 |
Why?
|
| Mass Screening | 3 | 2022 | 427 | 0.770 |
Why?
|
| Homosexuality, Male | 3 | 2017 | 438 | 0.760 |
Why?
|
| Early Detection of Cancer | 3 | 2022 | 292 | 0.740 |
Why?
|
| Neoplasms | 3 | 2016 | 1033 | 0.730 |
Why?
|
| Alphapapillomavirus | 3 | 2014 | 37 | 0.710 |
Why?
|
| Cross-Sectional Studies | 9 | 2023 | 2561 | 0.710 |
Why?
|
| Prevalence | 7 | 2023 | 1425 | 0.610 |
Why?
|
| Sex | 1 | 2016 | 3 | 0.600 |
Why?
|
| Colorectal Neoplasms | 1 | 2022 | 413 | 0.590 |
Why?
|
| Mother-Child Relations | 1 | 2016 | 55 | 0.580 |
Why?
|
| Communication | 2 | 2016 | 170 | 0.570 |
Why?
|
| Risk-Taking | 5 | 2023 | 435 | 0.570 |
Why?
|
| Community-Institutional Relations | 1 | 2017 | 171 | 0.550 |
Why?
|
| Penile Diseases | 1 | 2015 | 8 | 0.550 |
Why?
|
| Harm Reduction | 2 | 2011 | 20 | 0.510 |
Why?
|
| Consumer Health Information | 1 | 2014 | 22 | 0.500 |
Why?
|
| Papillomaviridae | 1 | 2015 | 125 | 0.500 |
Why?
|
| Health Personnel | 1 | 2016 | 200 | 0.500 |
Why?
|
| Information Seeking Behavior | 1 | 2014 | 23 | 0.500 |
Why?
|
| Mouth Diseases | 1 | 2014 | 6 | 0.490 |
Why?
|
| Gastroenterology | 1 | 2013 | 8 | 0.490 |
Why?
|
| Medical Oncology | 1 | 2013 | 26 | 0.480 |
Why?
|
| Socioeconomic Factors | 7 | 2016 | 1003 | 0.480 |
Why?
|
| Anal Canal | 1 | 2014 | 28 | 0.480 |
Why?
|
| Incidence | 6 | 2017 | 882 | 0.470 |
Why?
|
| Emigrants and Immigrants | 1 | 2015 | 125 | 0.470 |
Why?
|
| Physician-Patient Relations | 1 | 2014 | 118 | 0.460 |
Why?
|
| Penile Neoplasms | 1 | 2012 | 14 | 0.450 |
Why?
|
| Syphilis | 1 | 2013 | 27 | 0.450 |
Why?
|
| Education, Medical | 1 | 2013 | 97 | 0.440 |
Why?
|
| Attitude to Health | 1 | 2015 | 311 | 0.430 |
Why?
|
| Heroin | 1 | 2011 | 11 | 0.420 |
Why?
|
| Unsafe Sex | 2 | 2012 | 161 | 0.420 |
Why?
|
| Child | 4 | 2021 | 2875 | 0.400 |
Why?
|
| Health Status Disparities | 1 | 2017 | 583 | 0.390 |
Why?
|
| Seroepidemiologic Studies | 3 | 2023 | 67 | 0.390 |
Why?
|
| Promethazine | 1 | 2010 | 2 | 0.380 |
Why?
|
| United States | 6 | 2021 | 3894 | 0.370 |
Why?
|
| Self Medication | 1 | 2010 | 13 | 0.370 |
Why?
|
| Schools | 2 | 2021 | 229 | 0.360 |
Why?
|
| Feeding Behavior | 1 | 2013 | 418 | 0.360 |
Why?
|
| Hepatitis C, Chronic | 1 | 2010 | 39 | 0.360 |
Why?
|
| Health Behavior | 1 | 2013 | 491 | 0.360 |
Why?
|
| Time Factors | 5 | 2017 | 1681 | 0.360 |
Why?
|
| Age Factors | 4 | 2017 | 1007 | 0.360 |
Why?
|
| Vaccination | 2 | 2021 | 259 | 0.360 |
Why?
|
| Genotype | 4 | 2015 | 641 | 0.340 |
Why?
|
| Sexual Partners | 4 | 2017 | 308 | 0.340 |
Why?
|
| Aged | 8 | 2014 | 6448 | 0.330 |
Why?
|
| Emigration and Immigration | 1 | 2008 | 72 | 0.330 |
Why?
|
| Diet | 1 | 2014 | 747 | 0.320 |
Why?
|
| Age Distribution | 4 | 2014 | 223 | 0.310 |
Why?
|
| Breast Neoplasms | 1 | 2017 | 1426 | 0.290 |
Why?
|
| Vietnam | 3 | 2011 | 38 | 0.290 |
Why?
|
| Focus Groups | 2 | 2016 | 307 | 0.260 |
Why?
|
| Health Promotion | 1 | 2010 | 588 | 0.250 |
Why?
|
| Capacity Building | 2 | 2017 | 78 | 0.250 |
Why?
|
| Substance-Related Disorders | 1 | 2011 | 685 | 0.240 |
Why?
|
| Comorbidity | 2 | 2017 | 606 | 0.240 |
Why?
|
| Registries | 3 | 2014 | 330 | 0.240 |
Why?
|
| Hepacivirus | 1 | 2023 | 59 | 0.230 |
Why?
|
| Sex Factors | 2 | 2017 | 859 | 0.220 |
Why?
|
| Cost of Illness | 2 | 2014 | 79 | 0.210 |
Why?
|
| Cardiovascular Diseases | 1 | 2008 | 628 | 0.210 |
Why?
|
| Smoking | 3 | 2014 | 903 | 0.210 |
Why?
|
| Colonoscopy | 1 | 2022 | 98 | 0.210 |
Why?
|
| Sex Distribution | 3 | 2014 | 212 | 0.200 |
Why?
|
| Internet | 1 | 2021 | 204 | 0.180 |
Why?
|
| Poisson Distribution | 1 | 2017 | 39 | 0.150 |
Why?
|
| Sexual Abstinence | 1 | 2016 | 8 | 0.150 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 187 | 0.150 |
Why?
|
| Sex Education | 1 | 2016 | 29 | 0.150 |
Why?
|
| Biomedical Research | 2 | 2011 | 371 | 0.140 |
Why?
|
| Patient Compliance | 1 | 2017 | 202 | 0.140 |
Why?
|
| Cooperative Behavior | 1 | 2017 | 205 | 0.140 |
Why?
|
| Patient Education as Topic | 1 | 2017 | 207 | 0.140 |
Why?
|
| Dominican Republic | 1 | 2015 | 20 | 0.140 |
Why?
|
| Population Surveillance | 1 | 2017 | 231 | 0.130 |
Why?
|
| Risk Assessment | 1 | 2017 | 727 | 0.130 |
Why?
|
| HIV Seroprevalence | 1 | 2014 | 11 | 0.120 |
Why?
|
| Sentinel Surveillance | 1 | 2014 | 20 | 0.120 |
Why?
|
| Warts | 1 | 2013 | 5 | 0.120 |
Why?
|
| Human papillomavirus 16 | 1 | 2014 | 34 | 0.120 |
Why?
|
| Education, Medical, Continuing | 1 | 2013 | 31 | 0.120 |
Why?
|
| Guidelines as Topic | 1 | 2013 | 50 | 0.120 |
Why?
|
| Neoplasm Staging | 1 | 2014 | 269 | 0.120 |
Why?
|
| Guideline Adherence | 1 | 2013 | 82 | 0.120 |
Why?
|
| Linear Models | 1 | 2014 | 253 | 0.120 |
Why?
|
| Survival Rate | 1 | 2014 | 310 | 0.120 |
Why?
|
| Educational Measurement | 1 | 2013 | 80 | 0.120 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 211 | 0.120 |
Why?
|
| Survival Analysis | 1 | 2014 | 322 | 0.120 |
Why?
|
| Morbidity | 1 | 2013 | 94 | 0.110 |
Why?
|
| Confidence Intervals | 1 | 2013 | 151 | 0.110 |
Why?
|
| Health Facilities | 1 | 2013 | 23 | 0.110 |
Why?
|
| Data Collection | 1 | 2013 | 188 | 0.110 |
Why?
|
| Interviews as Topic | 1 | 2014 | 356 | 0.110 |
Why?
|
| Trust | 1 | 2014 | 119 | 0.110 |
Why?
|
| Epidemiologic Methods | 1 | 2012 | 44 | 0.110 |
Why?
|
| Health Surveys | 1 | 2014 | 358 | 0.110 |
Why?
|
| Culture | 1 | 2013 | 162 | 0.110 |
Why?
|
| Risk | 1 | 2013 | 256 | 0.110 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2014 | 176 | 0.110 |
Why?
|
| Logistic Models | 1 | 2015 | 894 | 0.110 |
Why?
|
| Ambulatory Care Facilities | 1 | 2012 | 61 | 0.110 |
Why?
|
| Internship and Residency | 1 | 2013 | 121 | 0.110 |
Why?
|
| Students, Medical | 1 | 2013 | 121 | 0.110 |
Why?
|
| Injections, Intravenous | 1 | 2011 | 58 | 0.110 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 239 | 0.110 |
Why?
|
| Physicians | 1 | 2013 | 148 | 0.100 |
Why?
|
| Vulnerable Populations | 1 | 2013 | 132 | 0.100 |
Why?
|
| Administration, Inhalation | 1 | 2011 | 75 | 0.100 |
Why?
|
| Prognosis | 1 | 2014 | 707 | 0.100 |
Why?
|
| Age of Onset | 1 | 2011 | 98 | 0.100 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 964 | 0.100 |
Why?
|
| Patient Selection | 1 | 2012 | 154 | 0.100 |
Why?
|
| Clinical Trials as Topic | 1 | 2012 | 195 | 0.100 |
Why?
|
| Health Status | 1 | 2014 | 356 | 0.100 |
Why?
|
| Drug Resistance, Viral | 1 | 2011 | 60 | 0.100 |
Why?
|
| Pilot Projects | 1 | 2012 | 628 | 0.090 |
Why?
|
| Aged, 80 and over | 2 | 2013 | 2333 | 0.090 |
Why?
|
| Anti-Retroviral Agents | 1 | 2011 | 139 | 0.090 |
Why?
|
| Quality of Life | 1 | 2014 | 459 | 0.090 |
Why?
|
| Health Services Accessibility | 1 | 2014 | 531 | 0.090 |
Why?
|
| Disease Progression | 1 | 2011 | 580 | 0.090 |
Why?
|
| Depression | 1 | 2014 | 664 | 0.080 |
Why?
|
| Minority Groups | 1 | 2012 | 537 | 0.080 |
Why?
|
| Acculturation | 1 | 2008 | 172 | 0.070 |
Why?
|
| Mexican Americans | 1 | 2008 | 177 | 0.070 |
Why?
|
| Prospective Studies | 1 | 2010 | 1353 | 0.070 |
Why?
|
| Obesity | 1 | 2013 | 965 | 0.070 |
Why?
|
| Body Piercing | 1 | 2005 | 2 | 0.070 |
Why?
|
| Tattooing | 1 | 2005 | 7 | 0.070 |
Why?
|
| HIV-1 | 1 | 2011 | 678 | 0.070 |
Why?
|
| Blood Transfusion | 1 | 2005 | 26 | 0.070 |
Why?
|
| Health Occupations | 1 | 2005 | 15 | 0.070 |
Why?
|
| Cohort Studies | 1 | 2008 | 1422 | 0.060 |
Why?
|
| Cocaine-Related Disorders | 1 | 2005 | 84 | 0.060 |
Why?
|
| Prostatic Neoplasms | 1 | 2012 | 794 | 0.060 |
Why?
|
| Medically Underserved Area | 1 | 2012 | 98 | 0.030 |
Why?
|
| New York City | 1 | 2011 | 212 | 0.020 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2011 | 203 | 0.020 |
Why?
|